PTEN and Proteus syndrome: Estimates vary, but germline PTEN alterations may remain unidentified in approximately 40% of individuals with a clinical diagnosis of BRRS (4), 80% of individuals with Proteus syndrome (4), and 15% of individuals with classic CS (4).